Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FHZ53
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,619
Award facts
- Contract value 100% obligated
- $22,619.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Dupixent 300 mg/2 ml syringes. The contract is valued at $22,619.31 and represents a firm fixed-price delivery order with an ultimate completion date of July 22, 2025. The performance location is the company's corporate office in Conshohocken, Pennsylvania. This is a non-set-aside award, indicating it was competitively awarded. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies critical medications and medical commodities to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The DLA Medical Supply Chain relies on AmerisourceBergen's extensive portfolio to fulfill pharmaceutical needs across multiple therapeutic domains. Dupixent (dupilumab) is a biologic immunosuppressant medication commonly used in military healthcare for treating moderate-to-severe eczema and other inflammatory conditions. This delivery order exemplifies the company's role as a key vendor supporting Department of Defense medical requirements through the DLA's pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DB25FHZ53?
SPE2DB25FHZ53 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FHZ53 worth?
The government has obligated $22,619 on SPE2DB25FHZ53.
Is contract SPE2DB25FHZ53 an order under another contract?
Yes. SPE2DB25FHZ53 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FHZ53 competed?
The extent of competition for SPE2DB25FHZ53 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award